Metis TechBio Raises HK$304 Million From IPO Overallotment Exercise

MT Newswires Live06-08

Metis TechBio (HKG:7666) said its underwriters fully exercised the overallotment option for its Hong Kong initial public offering, while the stabilization period ended on June 5, according to a same-day filing with the Hong Kong bourse.

The AI-driven nanotechnology company issued nearly 30.2 million H shares at HK$10.50 per share, generating additional net proceeds of about HK$304.2 million.

The overallotment option was exercised after the same number of shares were over-allocated by the underwriters in the international offering.

Metis TechBio said its public float remained in compliance with Hong Kong listing requirements following the exercise of the overallotment option.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment